Multi-year collaboration expected to identify novel drug targets, tackle new subsets of disease and enable rapid progression of clinical programs
Anne Wojcicki discusses how 23andMe is becoming a player in medical research for age-old genetic diseases
Using data from the UK Biobank and 23andMe, researchers found new genetic associations for allergies, asthma, and eczema by studying the age of onset.
The post Researchers Identify New Genetic Associations for Allergies, Asthma and Eczema appeared first on 23andMe Blog.
23andMe joined with seven other companies as a Founding Partner to assist in the launch of iHeartMedia’s BIN: Black Information Network.
The post 23andMe Becomes a Founding Partner For First and Only 24/7 All-News Audio Service Dedicated To The Black Community appeared first on 23andMe Blog.
Pride month is a time to celebrate the love that’s in all our DNA, regardless of someone’s sexual orientation or gender identity. But even though we are all 99.5 percent genetically identical, we still aren’t treated 100 percent equally. 23andme is doing its part to make sure employees and customers are treated equally no matter their sexual orientation or gender identity.
The post Celebrating Pride Month, a Spotlight on Sex and Gender appeared first on 23andMe Blog.
23andMe updated its G6PD Deficiency Genetic Health Risk Report* that now includes the two most common variants linked to G6PD deficiency, a condition that can lead to episodes of anemia. The update makes this report more comprehensive, and relevant for more people.
The post Improvements to 23andMe’s G6PD Deficiency Report appeared first on 23andMe Blog.